The International Journal of Tuberculosis and Lung Disease

Reexamining the role of radiography in tuberculosis case finding
pp. 1279-1279(1)
Author: Leung, Chi Chiu

Programmatic management of multidrug-resistant tuberculosis—15 years later
pp. 1280-1280(1)
Author: Nardell, Edward A.

Isoniazid preventive therapy for all: are we ready?
pp. 1281-1282(2)
Authors: Fenner, L.; Rieder, H.L.

Translating tuberculosis research into global policies: the example of an international collaboration on diagnostics
pp. 1283-1293(11)
Authors: Ramsay, A.; Steingart, K.R.; Cunningham, J.; Pai, M.

Programmatic management of multidrug-resistant tuberculosis: models from three countries
pp. 1294-1300(7)
Authors: Furin, J.; Bayona, J.; Becerra, M.; Farmer, P.; Golubkov, A.; Hurtado, R.; Joseph, J.K.; Keshavjee, S.; Ponomarenko, O.; Rich, M.; Shin, S.

Transforming growth factor-β1 polymorphisms and chronic obstructive pulmonary disease: a meta-analysis
pp. 1301-1307(7)
Authors: Zhang, L.; Chang, W-W.; Ding, H.; Su, H.; Wang, H-Y.

High sensitivity of chest radiograph reading by clinical officers in a tuberculosis prevalence survey
pp. 1308-1314(7)
Authors: Hoog, A.H. van't; Meme, H.K.; van Deutekom, H.; Mithika, A.M.; Olunga, C.; Onyino, F.; Borgdorff, M.W.

Bacteriologic monitoring of multidrug-resistant tuberculosis patients in five DOTS-Plus pilot projects
pp. 1315-1322(8)
Authors: Gammino, V.M.; Taylor, A.B.; Rich, M.L.; Bayona, J.; Becerra, M.C.; Bonilla, C.; Gelmanova, I.; Hollo, V.; Jaramillo, E.; Keshavjee, S.; Leimane, V.; Mitnick, C.D.; Quelapio, M.I.D.; Riektsina, V.; Tupasi, T.E.; Wells, C.D.; Zignol, M.; Cegielski, P.J.

Extensively drug-resistant tuberculosis: experience at the Tuberculosis Research Centre, Chennai, India
pp. 1323-1325(3)
Authors: Thomas, A.; Joseph, P.; Nair, D.; Rao, D.V.B.; Rekha, V.V.B.; Selvakumar, N.; Jaggarajamma, K.; Balambal, R.

Tuberculosis among household contacts of multidrug-resistant tuberculosis patients in Delhi, India
pp. 1326-1330(5)
Authors: Singla, N.; Singla, R.; Jain, G.; Habib, L.; Behera, D.

Recurrence after successful treatment among patients with multidrug-resistant tuberculosis
pp. 1331-1333(3)
Authors: Lee, J.; Lim, H-J.; Cho, Y-J.; Park, Y.S.; Lee, S-M.; Yang, S-C.; Yoo, C-G.; Kim, Y.W.; Han, S.K.; Yim, J-J.

Acceptance of interferon-gamma release assay by a high-risk urban cohort
pp. 1334-1339(6)
Authors: O'Donnell, M.R.; Coe, A.; Bliss, C.; Lee, D.; Tumilty, S.; Skolnik, P.R.; Horsburgh, C.R.; Cotton, D.; Saukkonen, J.

Potential cost-effectiveness of rifampin vs. isoniazid for latent tuberculosis: implications for future clinical trials
pp. 1340-1346(7)
Authors: Esfahani, K.; Aspler, A.; Menzies, D.; Schwartzman, K.

Incidence of tuberculosis in HIV-infected patients receiving HAART: interaction between TST and CD4 count
pp. 1347-1352(6)
Authors: Martín-Echevarria, E.; Rodríguez-Zapata, M.; Torralba, M.; Fernández, J.M.R.; Moreno, A.; Casado, J.L.; Dronda, F.; Pérez-Elías, M.J.; Navas, E.; Moreno, S.

Bleach treatment of sputum samples aids pulmonary tuberculosis screening among HIV-infected patients in Laos
pp. 1353-1358(6)
Authors: Thammavong, C.; Paboriboune, P.; Bouchard, B.; Harimanana, A.; Babin, F-X.; Phimmasone, P.; Berland, J-L.; Buisson, Y.

Screening and follow-up of children exposed to tuberculosis cases, Luanda, Angola
pp. 1359-1361(3)
Authors: Fortunato, I.; Sant'Anna, C.

Strengthening tuberculosis patient referral mechanisms among health facilities in Punjab, Pakistan
pp. 1362-1366(5)
Authors: Badar, D.; Ohkado, A.; Naeem, M.; Khurshid-Ul-Zaman, S.; Tsukamoto, M.

The experience of implementing a 'TB village' for a pastoralist population in Cherrati, Ethiopia
pp. 1367-1372(6)
Authors: Tayler-Smith, K.; Khogali, M.; Keiluhu, K.; Jemmy, J-P.; Ayada, L.; Weyeyso, T.; Issa, A.M.; De Maio, G.; Harries, A.D.; Zachariah, R.

'Sputnik': a programmatic approach to improve tuberculosis treatment adherence and outcome among defaulters
pp. 1373-1379(7)
Authors: Gelmanova, I.Y.; Taran, D.V.; Mishustin, S.P.; Golubkov, A.A.; Solovyova, A.V.; Keshavjee, S.

Predictors of change in nutritional and hemoglobin status among adults treated for tuberculosis in Tanzania
pp. 1380-1389(10)
Authors: Kawai, K.; Villamor, E.; Mugusi, F.M.; Saathoff, E.; Urassa, W.; Bosch, R.J.; Spiegelman, D.; Fawzi, W.W.

Risk factors for mortality in smear-negative tuberculosis suspects: a cohort study in Harare, Zimbabwe
pp. 1390-1396(7)
Authors: MacPherson, P.; Dimairo, M.; Bandason, T.; Zezai, A.; Munyati, S.S.; Butterworth, A.E.; Mungofa, S.; Rusakaniko, S.; Fielding, K.; Mason, P.R.; Corbett, E.L.

Hepatitis C virus infection in patients with tuberculosis in Central Brazil
pp. 1397-1402(6)
Authors: Reis, N.R.S.; Lopes, C.L.R.; Teles, S.A.; Matos, M.A.D.; Carneiro, M.A.S.; Marinho, T.A.; Filho, J.A. Araújo; Espírito-Santo, M.P.; Lampe, E.; Martins, R.M.B.

N-acetyltransferase 2 polymorphisms and risk of anti-tuberculosis drug-induced hepatotoxicity in Caucasians
pp. 1403-1408(6)
Authors: Leiro-Fernandez, V.; Valverde, D.; Vázquez-Gallardo, R.; Botana-Rial, M.; Constenla, L.; Agúndez, J.A.; Fernández-Villar, A.

Molecular identification of Mycobacterium bovis and the importance of zoonotic tuberculosis in Mexican patients
pp. 1409-1414(6)
Authors: Portillo-Gómez, L.; Sosa-Iglesias, E.G.

Use of soluble triggering receptor expressed on myeloid cells-1 in non-tuberculous mycobacterial lung disease
pp. 1415-1420(6)
Authors: Shu, C-C.; Lee, L-N.; Wu, M-F.; Lee, C-H.; Wang, J-T.; Wang, J-Y.; Yu, C-J; The TAMI Group,